| PTS | Sex | Age (at Diagnosis) | SOKAL | Pre-Imatinib Treatments | Months of Treatment with Imatinib 400 mg | Months of Treatment with Imatinib 600 mg |
|---|---|---|---|---|---|---|
| 1 | F | 31.9 | Int | IFN | 10 | 4 |
| 2 | M | 63.3 | High | IFN+HU | 6 | 3 |
| 3 | F | 47.3 | High | HU | 6 | 3 |
| 4 | M | 52.2 | Low | HU | 6 | 3 |
| 5 | F | 23.5 | Low | IFN | 9 | 4 |
| 6 | F | 46.6 | Int | None | 21 | NA |
| 7 | M | 40.1 | Low | IFN | 6 | 3 |
| 8 | M | 50.6 | Low | IFN+AraC | 15 | 16 |
| 9 | M | 47.7 | Low | IFN+AraC | 10 | 4 |
| 10 | M | 39.1 | Int | IFN+HU | 10 | NA |
| 11 | F | 66.4 | Int | None | 12 | 5 |